Oxford Instruments Confirms Outlook on Strong Q3 Orders

Strong Orders Uphold Annual Forecast

Oxford Instruments has reconfirmed its full-year financial expectations following a robust third-quarter performance. The company reported a group-wide year-to-date book-to-bill ratio of 1.2x, signaling strong demand for its products and services and providing clear visibility for future revenue.

Divisional Performance Overview

The Advanced Technologies division demonstrated exceptional growth, with year-to-date orders increasing by 44.5 percent year-over-year on a constant currency basis. The core Imaging and Analysis division also showed recovery, with order intake growing 2.4 percent in the third quarter after previous declines.

Financial and Strategic Moves

The company completed the divestment of its NanoScience business for net proceeds of £48.5 million and finalized a pension buy-in that will eliminate future contributions from fiscal year 2027. Management reaffirmed its fiscal year 2026 EBITA guidance of £70.2 million to £73.0 million, aligning with market expectations despite an anticipated currency headwind of approximately £5.5 million.

Summary and Outlook

Oxford Instruments maintains a positive outlook, supported by a healthy order book that provides coverage well into fiscal year 2027. The successful strategic initiatives and strong divisional performance position the company to navigate market conditions effectively.

FAQ

Q: What was the main driver of Oxford Instruments' strong performance?
A: The Advanced Technologies division was the main driver, with year-to-date orders surging 44.5% on a constant currency basis.

Q: Did Oxford Instruments change its financial forecast?
A: No, the company reaffirmed its fiscal year 2026 guidance for EBITA, keeping it in line with market expectations.

Source: Investing.com